Clinical features | Primary infection(n = 36) | Past infection(n = 92) | No infection(n = 111) |
---|---|---|---|
Age (months) | 41.8 ± 32.3* | 60.3 ± 37.7** | 37.7 ± 29.5* |
Male/female patients | 17/19 | 57/35 | 74/37 |
Length of stay (days) | 9.1 ± 4.1 | 7.8 ± 2.5* | 8.9 ± 3.9 |
Fever | 31 (86.1%) | 83 (90.2%) | 97 (87.4%) |
Cough | 30 (83.3%) | 65 (70.6%) | 85 (76.6%) |
Rash | 14 (38.9%)** | 17 (18.5%)* | 16 (14.4%)* |
Lymphadenopathy | 11 (30.6%) | 33 (35.9%) | 29 (1.8%)* |
Pharyngitis | 26 (72.2%) | 74 (80.4%) | 79 (71.2%) |
Palatal petechiae | 3 (8.3%) | 16 (17.4) | 20 (18.0%) |
Abnormal chest X ray | 7/20 (35.0%)** | 40/46 (87.0%)* | 49/61 (80.3%)* |
Hepatomegaly | 5 (5.4%) | 7 (6.3%) | |
Splenomegaly | 0 (0.0%) | 3 (3.3%) | 1 (0.9%) |
ALC >10% | 3/21 (14.3%) | 9/51 (17.7%) | 13/70 (18.6%) |
Elevated ESR | 10/21 (47.6%) | 35/67 (53.2%) | 30/63 (47.6%) |
Elevated CRP | 10/21 (47.6%) | 33/68 (48.5%) | 42/73 (57.5%) |
ALF | 4/18 (22.2%) | 3/24 (12.5%) | 12/33 (36.4%) |